UK markets closed

Novo Nordisk CEO on Earnings, 2020 Outlook, Coronavirus

Feb.05 -- Lars Fruergaard Jorgensen, chief executive officer of Novo Nordisk A/S, the world's biggest maker of insulin, discusses the coronavirus outbreak, the company's earnings and outlook for 2020. He speaks from Copenhagen on "Bloomberg Surveillance."